GFM
TVGN icon

GF Fund Management’s Tevogen Bio Holdings TVGN Stock Holding History

GF Fund Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-82
Closed -$3.21K – 701
2025
Q3 		$3.21K Sell
82
-2
-2% -$98 ﹤0.01% 616
2025
Q2 		$5.26K Hold
84
– – ﹤0.01% 622
2025
Q1 		$4.54K Buy
84
+10
+14% +$658 ﹤0.01% 629
2024
Q4 		$3.79K Buy
+74
New +$4.82K ﹤0.01% 620

Other funds holding TVGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

GF Fund Management's TVGN Position: Q4 2025 in Review

GF Fund Management sold out of Tevogen Bio Holdings (TVGN) in Q4 2025, closing a stake of 82 shares — an estimated $3.21K sold.

GF Fund Management first reported a position in TVGN in Q4 2024 and held it in 4 quarters. The position peaked at $5.26K in Q2 2025. 51 funds tracked by Wall St. Rank hold TVGN as of Q4 2025.

  • GF Fund Management reported no remaining Tevogen Bio Holdings position as of Q4 2025 after selling out during the quarter.
  • GF Fund Management sold 82 Tevogen Bio Holdings shares in Q4 2025, an estimated $3.21K.
  • GF Fund Management first reported a position in Tevogen Bio Holdings in Q4 2024 and held it in 4 quarters.
  • GF Fund Management's Tevogen Bio Holdings position peaked at $5.26K in Q2 2025.
  • 51 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q4 2025.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.